1. Home
  2. AMS vs MBRX Comparison

AMS vs MBRX Comparison

Compare AMS & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Shared Hospital Services

AMS

American Shared Hospital Services

N/A

Current Price

$1.45

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

N/A

Current Price

$0.50

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMS
MBRX
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
10.1M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
AMS
MBRX
Price
$1.45
$0.50
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $12.00
AVG Volume (30 Days)
7.2K
★ 1.1M
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $19,714,000.00
N/A
Revenue This Year
$16.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 0.81
N/A
52 Week Low
$1.25
$0.16
52 Week High
$2.58
$7.98

Technical Indicators

Market Signals
Indicator
AMS
MBRX
Relative Strength Index (RSI) 44.83 35.94
Support Level $1.37 $0.50
Resistance Level $1.63 $0.67
Average True Range (ATR) 0.04 0.09
MACD -0.00 -0.00
Stochastic Oscillator 11.11 3.96

Price Performance

Historical Comparison
AMS
MBRX

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: